Neurotrophic keratitis is an orphan disease with a global prevalence rate of 5 per 10,000 people. It is manifested by the damage of trigeminal nucleus nerve innervations present in the eye corneal region which dampens the healing process of corneal injuries. The treatment approach is adopted as per the different stages of the disease.
This report contains market size and forecasts of Neurotrophic Keratitis Treatment in Global, including the following market information:
Global Neurotrophic Keratitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neurotrophic Keratitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Preservative Free Artificial Tears Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neurotrophic Keratitis Treatment include Allergan, Plc., Abbott Laboratories, Inc., Bausch & Lomb Incorporated, Bayer AG, CooperVision, Dompe farmaceutici S.p.A., Johnson & Johnson, Novartis AG and ReGenTree, LLC. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurotrophic Keratitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurotrophic Keratitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neurotrophic Keratitis Treatment Market Segment Percentages, by Type, 2021 (%)
Preservative Free Artificial Tears
Topical Antibiotics
Tarsorraphy
Amniotic Membrane Transplantation
Bandage Contact Lenses
Recombinant Human Nerve Growth Factor
Global Neurotrophic Keratitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neurotrophic Keratitis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Neurotrophic Keratitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neurotrophic Keratitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurotrophic Keratitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neurotrophic Keratitis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan, Plc.
Abbott Laboratories, Inc.
Bausch & Lomb Incorporated
Bayer AG
CooperVision
Dompe farmaceutici S.p.A.
Johnson & Johnson
Novartis AG
ReGenTree, LLC.
Walgreens